Kiadis Pharma
is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer... Read moreKiadis Pharma
is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer... Read more
News
Jul 15, 2021
CompanyNews HQ
Kiadis Pharma: Conversion of Kiadis to a private limited liability company postponed until completion of statutory buy-out proceedings
May 13, 2021
centralcharts
Press Release: Kiadis Pharma : Notice of Annual General Meeting of Shareholders
May 13, 2021
MarketScreener
Kiadis Pharma: Kiadis Pharma N : AGM QA Protocol
Apr 29, 2021
CompanyNews HQ
Kiadis Pharma: Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer
Apr 26, 2021
StreetInsider
Press Release: Kiadis Pharma : Delisting of Kiadis will be effective on 25 May 2021
Apr 17, 2021
CompanyNews HQ
Kiadis Pharma: Sanofi completes Kiadis acquisition
Apr 14, 2021
MarketScreener
Kiadis Pharma: Kiadis Pharma N : Minutes of the EGM held on 30 March 2021
Apr 09, 2021
StreetInsider
Press Release: Kiadis Pharma : Kiadis employee options committed under the Sanofi Offer
Apr 07, 2021
Benzinga
Kiadis Pharma: Kiadis Pharma announces annual results for the year ended December 31, 2020
Mar 30, 2021
StreetInsider
Press Release: Kiadis Pharma : Kiadis EGM adopts all resolutions related to the recommended public offer by Sanofi
Kiadis Pharma Competitors
1
2
3
4
5
6
7
8
9
10